We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 123

Pfizer v Ranbaxy; 55.2 proceeding; October 5, 2007 - atorvastatin

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 25 2007

The trial judge granted prohibition in respect of one patent claiming a novel crystalline form of atorvastatin (the "crystalline form patent") and denied prohibition in respect of another patent claiming a novel process for making atorvastatin (the "process patent"

Apotex v. Pfizer

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • March 4 2009

The Court of Appeal dismissed the generic company's appeal and upheld the decision of the trial judge prohibiting Apotex entering the market until the expiry of the patent

Sanofi-Aventis v. Laboratoire Riva; interlocutory motion on 55.2 proceeding; December 14, 2007 - Ramipril

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 17 2008

After cross-examinations had taken place, and approximately one week before the application record of Sanofi-Aventis was due, Riva brought a motion for leave to file further evidence

AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing

Canada (Attorney General) v. Celgene Corporation, appeal of a PMPRB decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 20 2010

The Court of Appeal overturned the decision of the Trial Judge and restored the decision of the PMPRB providing jurisdiction to the PMPRB over medicines imported under the Special Access Program

Recent cases

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 21 2009

The Court granted an order of prohibition to Purdue in the face of Pharmascience’s allegations that the patent was invalid

Lundbeck v. Cobalt, Genpharm and Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 7 2009

The Court granted prohibition in respect of each of the proceedings against each defendant

Abbott Laboratories Limited et al. v. The Minister of Health et al

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 20 2007

In this decision, the Court again dismissed a motion by an innovator to reverse the order of evidence in a 55.2 proceeding

Novopharm v. Eli Lilly, appeals of decisions of the Case Management Prothonotary

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Eli Lilly appealed two interlocutory decisions made by the Case Management Prothonotary

Sanofi v. Hospira, merits of a 55.2 proceeding

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 3 2009

The Court refused to grant an Order of Prohibition against Hospira regarding its docetaxel product